Description
ASHG’s two-day virtual symposium Cardiogenetics 2026 — Omics, Regulation & AI for Precision Cardiovascular Medicine — brings together leading researchers who are working to advance our understanding and treatment of the genetic underpinnings of cardiovascular disease and health. Over two days, speakers will highlight cutting‑edge discoveries spanning transcriptomic profiling, non‑coding variant interpretation, enhancer–gene regulatory architecture, and cardiomyopathy‑relevant GWAS. Together, these sessions underscore a rapidly evolving landscape in which regulatory genomics, advanced omics technologies, and artificial intelligence converge to accelerate precision cardiovascular medicine. This symposium provides a platform for interdisciplinary dialogue toward translating genetic insights into improved prediction, diagnosis, and therapeutic strategies for heart and metabolic diseases.
